 NEW YORK, Jan. 04, 2022 GLOBE NEWSWIRE -- Protara Therapeutics, Inc. Nasdaq: TARA, a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that management will present at the H.C. Wainwright BioConnect Virtual Conference being held from January 10-13, 2022. 